Nasdaq Nordic: Nasdaq Stockholm Welcomes IRLAB to the Main Market

Stockholm, September 30, 2020 - Nasdaq (Nasdaq: NDAQ) announces that trading in
IRLAB Therapeutics AB's shares (short name: IRLAB A) will commence today on the
Nasdaq Stockholm main market. The company belongs to the Health Care sector and
is the 41st company to be admitted to trading on Nasdaq's Nordic markets* in
2020. IRLAB's shares were previously traded on the Nasdaq First North Premier
Growth Market. 

IRLAB a Swedish company dedicated to the discovery and development of new drugs
for treatment of Parkinson's disease and other life-altering diseases that
affect the central nervous system. As the population of elderly is growing
worldwide, diseases triggered by an aging brain are expected to grow
dramatically. Nearly 13 million people are expected to have developed
Parkinson's disease by 2040. Hence, the need for effective treatments is
increasing. IRLAB is headquartered in Gothenburg. 

"Today is an important day for us. Moving from First North to the Main Market
marks a fantastic milestone in our growth journey," said Nicholas Waters, CEO
of IRLAB. "The support from existing, and the welcoming of new, shareholders
will enable us in our mission to transform everyday life for patients with
Parkinson's disease." 

"We are proud to welcome IRLAB, an innovative leader within its field with an
important purpose. We look forward to continue our support of IRLAB by
providing unmatched liquidity and visibility," said Adam Kostyál, Head of
European Listings at Nasdaq. "More and more health care companies are looking
to be listed with Nasdaq Stockholm. This contributes to invaluable medical
advances and discoveries while strengthening Stockholm's role as an important
health tech hub in Europe." 

*Main markets and Nasdaq First North at Nasdaq Copenhagen, Nasdaq Helsinki,
Nasdaq Iceland and Nasdaq Stockholm 

About Nasdaq

Nasdaq (Nasdaq: NDAQ) is a global technology company serving the capital
markets and other industries. Our diverse offering of data, analytics, software
and services enables clients to optimize and execute their business vision with
confidence. To learn more about the company, technology solutions and career
opportunities, visit us on LinkedIn, on Twitter @Nasdaq, or at www.nasdaq.com 

Nasdaq Media Contact

Rebecka Wulfing

[phone]

[e-mail]